Transition Bio has filed a notice of an exempt offering of securities to raise $15,000,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, Transition Bio is raising $15,000,000.00 in new funding. Sources indicate that as part of senior management Co-Founder, Samuel Cohen played a key role in securing…
